rs5743315

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_003265.3(TLR3):​c.633+231C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0375 in 152,170 control chromosomes in the GnomAD database, including 224 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.038 ( 224 hom., cov: 32)

Consequence

TLR3
NM_003265.3 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.169

Publications

16 publications found
Variant links:
Genes affected
TLR3 (HGNC:11849): (toll like receptor 3) The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns (PAMPs) that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. This receptor is most abundantly expressed in placenta and pancreas, and is restricted to the dendritic subpopulation of the leukocytes. It recognizes dsRNA associated with viral infection, and induces the activation of NF-kappaB and the production of type I interferons. It thus plays a role in host defense against multiple viruses. [provided by RefSeq, Jul 2021]
TLR3 Gene-Disease associations (from GenCC):
  • immunodeficiency 83, susceptibility to viral infections
    Inheritance: AD, Unknown, AR Classification: STRONG, LIMITED Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_003265.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.094 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003265.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TLR3
NM_003265.3
MANE Select
c.633+231C>A
intron
N/ANP_003256.1O15455-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TLR3
ENST00000296795.8
TSL:1 MANE Select
c.633+231C>A
intron
N/AENSP00000296795.3O15455-1
TLR3
ENST00000513189.1
TSL:1
n.633+231C>A
intron
N/AENSP00000423386.1D6RA51
TLR3
ENST00000949725.1
c.633+231C>A
intron
N/AENSP00000619784.1

Frequencies

GnomAD3 genomes
AF:
0.0375
AC:
5706
AN:
152052
Hom.:
222
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0965
Gnomad AMI
AF:
0.0418
Gnomad AMR
AF:
0.0281
Gnomad ASJ
AF:
0.0337
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00353
Gnomad FIN
AF:
0.00726
Gnomad MID
AF:
0.130
Gnomad NFE
AF:
0.0136
Gnomad OTH
AF:
0.0339
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0375
AC:
5712
AN:
152170
Hom.:
224
Cov.:
32
AF XY:
0.0357
AC XY:
2655
AN XY:
74388
show subpopulations
African (AFR)
AF:
0.0965
AC:
4006
AN:
41508
American (AMR)
AF:
0.0280
AC:
427
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.0337
AC:
117
AN:
3468
East Asian (EAS)
AF:
0.000194
AC:
1
AN:
5164
South Asian (SAS)
AF:
0.00374
AC:
18
AN:
4812
European-Finnish (FIN)
AF:
0.00726
AC:
77
AN:
10600
Middle Eastern (MID)
AF:
0.122
AC:
36
AN:
294
European-Non Finnish (NFE)
AF:
0.0136
AC:
922
AN:
68024
Other (OTH)
AF:
0.0331
AC:
70
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
269
538
807
1076
1345
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
54
108
162
216
270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00278
Hom.:
0
Bravo
AF:
0.0428
Asia WGS
AF:
0.0110
AC:
40
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
1.2
DANN
Benign
0.55
PhyloP100
-0.17
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs5743315;
hg19: chr4-187000416;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.